Apolipoprotein A-V dependent modulation of plasma triacylglycerol: A puzzlement

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1821, Issue 5, 2012, Pages 795-799

  Sharma, Vineeta ^a   Ryan, Robert O ^a   Forte, Trudy M ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

Apolipoprotein A V; Genome wide association study; Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1; Lipid droplet; Nonalcoholic fatty liver disease; Triglyceride

Indexed keywords

APOLIPOPROTEIN A5; CELL PROTEIN; CYTOPLASM PROTEIN; FAT DROPLET; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED HIGH DENSITY LIPOPROTEIN BINDING PROTEIN 1; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LIPOPROTEIN LIPASE; LIPOPROTEIN RECEPTOR; OLEIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

GENE FREQUENCY; GENE INACTIVATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LIPID HYDROLYSIS; LIPID LIVER LEVEL; LIPID TRANSPORT; LIPOGENESIS; LIPOPROTEIN METABOLISM; LIPOTOXICITY; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN HYDROLYSIS; PROTEIN LIPID INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; APOLIPOPROTEINS A; CARRIER PROTEINS; FATTY LIVER; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LIPID METABOLISM; MICE; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES;

EID: 84859163688     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2011.12.002     Document Type: Review

References (40)

1. P.J. O'Brien, W.E. Alborn, J.H. Sloan, M. Ulmer, A. Boodhoo, M.D. Knierman, A.E. Schultze, and R.J. Konrad The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins Clin. Chem. 51 2005 351 359
2. L.A. Pennacchio, M. Olivier, J.A. Hubacek, J.C. Cohen, D.R. Cox, J.C. Fruchart, R.M. Krauss, and E.M. Rubin An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing Science 294 2001 169 173
3. H.N. Van der Vliet, M.G. Sammels, A.C. Leegwater, J.H. Levels, P.H. Reitsma, W. Boers, and R.A. Chamuleau Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration J. Biol. Chem. 276 2001 44512 44520
4. T.M. Forte, X. Shu, and R.O. Ryan The ins (cell) and outs (plasma) of apolipoprotein A-V J. Lipid Res. 50 2009 S150 S155 (Suppl)
5. C.T. Johansen, and R.A. Hegele Genetic bases of hypertriglyceridemic phenotypes Curr. Opin. Lipidol. 22 2011 247 253
6. C.T. Johansen, S. Kathiresan, and R.A. Hegele Genetic determinants of plasma triglycerides J. Lipid Res. 52 2011 189 206
7. T.M. Teslovich, K. Musunuru, and A.V. Smith Biological, clinical, and population relevance of 95 loci mapped for serum lipid concentrations Nature 466 2010 707 713
8. C.T. Johansen, J. Wang, M.B. Lanktree, H. Cao, A.D. McIntyre, M.R. Ban, R.A. Martins, B.A. Kennedy, R.G. Hassell, M.E. Visser, S.M. Schwartz, B.F. Voight, R. Elosua, V. Salomaa, C.J. O'Donnell, G.M. Dallinga-Thie, S.S. Anand, S. Yusuf, M.W. Huff, S. Kathiresan, and R.A. Hegele Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia Nat. Genet. 42 2010 684 687
9. P. Henneman, F.G. Schaap, L.M. Havekes, P.C.N. Rensen, R.R. Frants, A. van Tol, H. Hattori, A.H.M. Smelt, and K.W. van Dijk Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism Atherosclerosis 193 2007 129 134
10. L.A. Pennacchio, M. Olivier, J.A. Hubacek, R.M. Krauss, E.M. Rubin, and J.C. Cohen Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels Hum. Mol. Genet. 11 2002 3031 3038
11. J. Palmen, A.J. Smith, B. Dorfmeister, W. Putt, S.E. Humphries, and P.J. Talmud The functional interaction on in vitro gene expression of APOA5 SNPs, defining haplotype APOA52, and their paradoxical association with plasma triglyceride but not plasma apoAV levels Biochim. Biophys. Acta 1782 2008 447 452
12. P.J. Talmud, J. Palmen, W. Putt, L. Lins, and S.E. Humphries Determination of the functionality of common APOA5 polymorphisms J. Biol. Chem. 280 2005 28215 28220
13. J.T. Kao, H.C. Wen, K.L. Chien, H.C. Hsu, and S.W. Lin A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia Hum. Mol. Genet. 12 2003 2533 2539
14. Y. Tang, P. Sun, D. Guo, A. Ferro, Y. Ji, Q. Chen, and L. Fan Hum. Mol. Genet. 12 2003 2533 2539
15. C.R. Pullinger, B.E. Aouizerat, I. Movsesyan, V. Durlach, E.J. Sijbrands, K. Nakajima, A. Poon, G.M. Dallinga-Thie, H. Hattori, L.L. Green, P.Y. Kwok, R.J. Havel, P.H. Frost, M.J. Malloy, and J.P. Kane An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients J. Lipid Res. 49 2008 1846 1854
16. Lookene, J.A. Beckstead, S. Nilsson, G. Olivecrona, and R.O. Ryan Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism J. Biol. Chem. 280 2005 25383 25387
17. S.K. Nilsson, A. Lookene, J.A. Beckstead, G. Gliemann, R.O. Ryan, and G. Olivecrona Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family Biochemistry 46 2007 3896 3904
18. A.P. Beigneux, B. Davies, P. Gin, M.M. Weinstein, E. Farber, X. Qiao, F. Peale, S. Bunting, R.R. Walzem, J.S. Wong, W.S. Blaner, Z. Ding, K. Melford, N. Wongsiriroj, X. Shu, F. de Sauvage, R.O. Ryan, L.G. Fong, A. Bensadoun, and S.G. Young Glycosylphosphatidyl-inositol-anchored high density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons Cell Metab. 5 2007 279 291
19. P. Gin, L. Yin, B.S.J. Davies, M.M. Weinstein, R.O. Ryan, A. Bensadoun, L.G. Fong, S.G. Young, and A.P. Beigneux The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons J. Biol. Chem. 283 2008 29554 29562
20. X. Shu, L. Nelbach, M.M. Weinstein, B.L. Burgess, J.A. Beckstead, S.G. Young, R.O. Ryan, and T.M. Forte Intravenous injection of apolipoprotein A-V reconstituted high density lipoprotein decreases hypertriglyceridemia in apoav-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 Atheroscler. Thromb. Vasc. Biol. 30 2010 2504 2509
21. S.F.C. Vaessen, G.M. Dalllinga-Thie, C.J.D. Ross, L.J. Splint, L.W. Castellani, P.C.N. Rensen, M.R. Hayden, F.G. Schaap, and J.A. Kuivenhoven Plasma apolipoprotein AV levels in mice are positively associated with plasma triglyceride levels J. Lipid Res. 50 2009 880 884
22. F.G. Schaap, P.C. Rensen, P.J. Voshol, C. Vrins, H.N. van der Vliet, R.A. Chamuleau, L.M. Havekes, A.K. Groen, and K.W. van Dijk ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis J. Biol. Chem. 279 2004 27941 27947
23. X. Shu, J. Chan, R.O. Ryan, and T.M. Forte ApoA-V association with intracellular lipid droplets J. Lipid Res. 48 2007 1445 1450
24. H.N. van der Vliet, F.G. Schaap, J.H. Levels, R. Ottenhoff, N. Looije, J.G. Wesseling, A.K. Groen, and R.A. Chamuleau Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice Biochem. Biophys. Res. Commun. 295 2002 1156 1159
25. X. Shu, R.O. Ryan, and T.M. Forte Intracellular lipid droplet targeting by apolipoprotein A-V requires the carboxyl-terminal segment J. Lipid Res. 49 2008 1670 1676
26. L.B.M. Tijburg, C.B. Nyathi, G.W. Meijer, and M.J.H. Geelen Biosynthesis and secretion of triacylglycerol in rat liver after partial hepatectomy Biochem. J. 277 1991 723 728
27. G.C. Farrell Probing Prometheus: fat fueling the fire? J. Hepatol. 40 2004 1252 1255
28. X. Shu, L. Nelbach, R.O. Ryan, and T.M. Forte Apolipoprotein A-V associates with intrahepatic lipid droplets and influences triglyceride accumulation Biochim. Biophys. Acta 1801 2010 605 608
29. N. Pamir, T.S. McMillen, Y.I. Li, C.M. Lai, H. Wong, and R.C. LeBoeuf Overexpression of apolipoprotein A5 in mice is not protective against body weight gain and aberrant glucose homeostasis Metabolism 58 2009 560 567
30. A.M. Blade, M.A. Fabritius, L. Hou, R.B. Weinberg, and G.S. Shelness Biogenesis of apolipoprotein A-V and its impact on VLDL triglyceride secretion J. Lipid Res. 52 2011 237 244
31. S. Martin, and R.G. Parton Lipid droplets: a unified view of a dynamic organelle Nat. Rev. Mol. Cell Biol. 7 2006 373 378
32. H.L. Ploegh A lipid-based model for the creation of an escape hatch from the endoplasmic reticulum Nature 448 2007 435 438
33. J.A. Beckstead, K. Wong, V. Gupta, C.-P. Wan, V.R. Cook, R.B. Weinberg, P.M.M. Weers, and R.O. Ryan The effect of C-terminal truncation on the structural and lipid binding properties of apolipoprotein A-V J. Biol. Chem. 282 2007 15484 15489
34. S.J. Hickenbottom, A.R. Kimmel, C. Londos, and J.H. Hurley Structure of a lipid droplet protein; the PAT family member TIP47 Structure 12 2004 1199 1207
35. M. Lamant, F. Smih, R. Harmancey, P. Philip-Couderc, A. Pathak, J. Roncalli, M. Galinier, X. Collet, P. Massabuau, J.M. Senard, and P. Rouet ApoO, a novel apolipoprotein, is an original glycoprotein up-regulated by diabetes in human heart J. Biol. Chem. 281 2006 36289 36302
36. J.D. Browning, and J.D. Horton Molecular mediators of hepatic steatosis and liver injury J. Clin. Invest. 114 2004 147 152
37. I.J. Goldberg, and H.N. Ginsberg Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease Gastroenterology 130 2006 1343 1346
38. N.M. de Alwis, and C.P. Day Non-alcoholic fatty liver disease: the mist gradually clears J. Hepatol. 48 2008 104 112 (Suppl.)
39. T.C. Schreuder, B.J. Verwer, C.M. van Nieuwkerk, and C.J. Mulder Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment World J. Gastroenterol. 14 2008 2474 2486
40. C. Ress, A.R. Moschen, N. Sausgruber, A. Tschoner, I. Graziadei, H. Weiss, W. Schgoer, C.F. Ebenbichler, R.J. Konrad, J.R. Patsch, H. Tilg, and S. Kaser The role of apolipoprotein A5 in non-alcoholic fatty liver disease Gut 60 2011 985 991